Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-28

Clinical Trial Update: Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping [NA]

View source ↗

Summary

A clinical trial update focusing on rhythmic risk in Brugada syndrome and mapping of the pulmonary infundibulum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Brugada Syndrome Type 1 | NA | Status: UNKNOWN